Monroe Bank & Trust’s Novo Nordisk NVO Stock Holding History

Monroe Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$23K	–	191
2018 Q2	$23K	Hold	1,000	–	–	0.01%	178
2018 Q1	$25K	Hold	1,000	–	–	0.01%	185
2017 Q4	$27K	Buy	+1,000	New	+$25.4K	0.01%	187
2017 Q3	–	Sell	-1,000	Closed	-$21K	–	206
2017 Q2	$21K	Hold	1,000	–	–	0.01%	199
2017 Q1	$17K	Hold	1,000	–	–	0.01%	209
2016 Q4	$18K	Buy	+1,000	New	+$18.1K	0.01%	214
2016 Q2	–	Sell	-1,000	Closed	-$27K	–	253
2016 Q1	$27K	Hold	1,000	–	–	0.01%	213
2015 Q4	$29K	Hold	1,000	–	–	0.01%	201
2015 Q3	$27K	Hold	1,000	–	–	0.01%	205
2015 Q2	$27K	Hold	1,000	–	–	0.01%	201
2015 Q1	$27K	Hold	1,000	–	–	0.01%	203
2014 Q4	$21K	Buy	+1,000	New	+$22.3K	0.01%	217
2014 Q3	–	Sell	-1,000	Closed	-$23K	–	225
2014 Q2	$23K	Hold	1,000	–	–	0.01%	234
2014 Q1	$23K	Hold	1,000	–	–	0.01%	241
2013 Q4	$18K	Hold	1,000	–	–	0.01%	235
2013 Q3	$17K	Hold	1,000	–	–	0.01%	230
2013 Q2	$15K	Buy	+1,000	New	+$16.6K	0.01%	229

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Monroe Bank & Trust's NVO Position: Q3 2018 in Review

Monroe Bank & Trust sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 1,000 shares — an estimated $23K sold.

Monroe Bank & Trust first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $29K in Q4 2015. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

Monroe Bank & Trust reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
Monroe Bank & Trust sold 1,000 Novo Nordisk shares in Q3 2018, an estimated $23K.
Monroe Bank & Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
Monroe Bank & Trust's Novo Nordisk position peaked at $29K in Q4 2015.
557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Monroe Bank & Trust's 13F filing for Q3 2018, filed 14 Nov 2018.